[Myocardial hyperexcitability in decompensated cardiopathies. Effect of spironolactone].
D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D003681:Dehydration / Q000139:chemically induced; D004071:Digitalis Glycosides / Q000009:adverse effects; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate; D006400:Hematocrit; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications; D009584:Nitrogen / Q000097:blood; D011188:Potassium / Q000502:physiology / Q000627:therapeutic use; D012964:Sodium / Q000502:physiology; D013148:Spironolactone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014693:Ventricular Fibrillation
D004071:Digitalis Glycosides; D004232:Diuretics; D013148:Spironolactone; D012964:Sodium; D009584:Nitrogen; D011188:Potassium
L'hyperexcitablitité myocardique des cardiopathies décompensées. Effect de la spironolactone.